Instalab
logoInstalab

Free Testosterone

Blood Test
When standard testosterone results don't match how you feel, this reveals what's actually available to your cells.
4.9 (4,257 reviews)
Tested by Quest, Access Medical or Boston Heart
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a Free Testosterone test?

This test is most useful if any of these apply to you.

Total Testosterone Came Back Borderline
When your total testosterone sits near the lower edge of normal, this test can tell whether your active testosterone is actually low.
Symptoms Without a Clear Explanation
If low libido, fatigue, or reduced strength don't match a normal total testosterone, this can reveal what the standard test misses.
Managing Weight or Insulin Resistance
Obesity and insulin resistance shift the proteins that bind testosterone, so this gives a more accurate read on your active hormone.
Investigating PCOS or Androgen Excess
For irregular cycles, acne, or unwanted hair growth, this can flag androgen excess that a total testosterone alone might not catch.

About Free Testosterone

You feel tired, weaker, less driven, or your libido has dropped, but your total testosterone came back "normal." That mismatch is exactly why free testosterone exists. Total testosterone counts every molecule in your blood, including the ones locked to carrier proteins. The fraction bound tightly to SHBG is biologically unavailable, while albumin-bound testosterone can dissociate at the tissue level and contribute to what is called the bioavailable fraction. Your body's response is driven primarily by the small fraction that is unbound and freely available to enter cells.

This test uses the Vermeulen calculation, which estimates free testosterone (the unbound, active form) from your total testosterone, SHBG (sex hormone-binding globulin, the main protein that traps testosterone), and albumin. It is the calculated estimate most widely used by clinical labs, and the one recommended when total testosterone sits near the lower edge of normal or when your carrier proteins are shifted by age, weight, or illness.

Why Total Testosterone Alone Can Mislead You

About 96 to 99 percent of the testosterone in your blood is bound to carrier proteins, mainly SHBG and albumin. Only roughly 1 to 4 percent floats free and can slip into cells to signal muscle growth, libido, energy, and bone maintenance. When SHBG rises or falls, the total number on your lab report can stay steady while the biologically active fraction shifts dramatically.

SHBG rises with age, hyperthyroidism, and liver disease, and drops with obesity, insulin resistance, and diabetes. Two men with identical total testosterone can have very different free testosterone if their SHBG is different. That is why guidelines specifically recommend adding free testosterone when total testosterone lands near the lower limit of normal, when SHBG is likely altered, or when hypogonadal symptoms don't match the total number.

In one large European study, symptoms of low testosterone in aging men tracked more closely with low free testosterone than with low total testosterone. And a rare case of a man with essentially no SHBG showed normal reproductive development and fertility despite a low total testosterone, because his free testosterone stayed in range. He did report fatigue, muscle weakness, and reduced exercise tolerance, so he was not entirely asymptomatic, but his androgen-dependent development and fertility were preserved. The active fraction is what your body actually sees.

Sexual Function and Symptoms of Androgen Deficiency

Low free testosterone is more consistently tied to reduced libido, erectile dysfunction, and other symptoms of androgen deficiency than total testosterone in men over 40. In the European Male Ageing Study of 3,369 men aged 40 to 79, sexual symptoms such as poor morning erection, low sexual desire, and erectile dysfunction had a syndromic association with low testosterone, and hypogonadal symptoms were better explained by low free testosterone than by low total testosterone alone.

In treatment settings, this pattern shows up again. In the TRAVERSE substudy of 1,161 men with low libido and testosterone under 300 ng/dL, testosterone replacement produced measurable improvements in sexual activity by 6 months and held that benefit at 24 months. Because calculated free testosterone has inherent limitations, directly measured free testosterone by equilibrium dialysis is often considered more precise for predicting symptoms, though calculated free testosterone remains the most accessible option in routine care.

Prostate Cancer

The relationship between free testosterone and prostate cancer is more complex than "more testosterone means more cancer." A pooled analysis of 20 prospective studies found that men in the lowest tenth of free testosterone had about 23 percent lower risk of overall prostate cancer (OR 0.77, 95% CI 0.69 to 0.86), but showed nonsignificant hints of higher risk for aggressive, high-grade disease. Mendelian randomization studies, which use genetics to reduce confounding, found that higher free testosterone was associated with about 20 percent higher risk of overall prostate cancer and about 23 percent higher odds of aggressive disease per standard deviation increase.

What this means for you: free testosterone is one input into prostate cancer risk, not a diagnosis. If your level is high and you are older, or you have a family history, prostate screening becomes part of the conversation, not a reason to panic. If you are considering testosterone therapy, your clinician will layer PSA, prostate exam, and symptoms into the decision.

Bone Health and Frailty

Calculated free testosterone is linked to bone health and frailty in older men. Standard clinical practice already recommends measuring testosterone in men with osteoporosis or low-trauma fractures, because low androgen exposure is a treatable contributor to bone loss. Free testosterone often catches this pattern earlier than total testosterone, especially in older men whose SHBG has drifted upward with age.

Mortality in Serious Illness

In 191 men with advanced chronic liver disease awaiting transplant, low free testosterone was linked to greater frailty and about twice the mortality risk after adjusting for liver disease severity. Low total testosterone in the same group did not independently predict mortality. This is a specific, hospitalized population, but it illustrates a broader point: when a body is under real strain, the biologically active testosterone fraction reflects reserve and resilience better than the total number.

Heart Failure and Cardiometabolic Signals

In a study of 2,078 older men referred for coronary angiography, men in the highest quarter of free testosterone had about 62 percent lower risk of dying from congestive heart failure compared with the lowest quarter (HR 0.38, 95% CI 0.17 to 0.87). However, free testosterone was not linked to sudden cardiac death or fatal heart attack in the same cohort. In cohort data, men in the top quarter of calculated free testosterone had lower risk of developing type 2 diabetes than the bottom quarter.

These associations are not universal. Larger, more recent cohort data, including analyses in the UK Biobank of over 210,000 men, have shown mixed results, with some analyses linking lower calculated free testosterone to lower incidence of major adverse cardiovascular events. Free testosterone reflects overall metabolic and endocrine health as much as it drives it, so a low number is often a signal to look at weight, sleep, insulin resistance, and general health, not just the hormone itself.

Female Androgen Excess

In women, free testosterone is used mainly to look for androgen excess, not deficiency. It plays a role in evaluating polycystic ovary syndrome (PCOS), congenital adrenal hyperplasia, unexplained hirsutism, and rare androgen-producing tumors. In these settings, a directly measured free testosterone often outperforms both total testosterone and calculated free testosterone. Interpretation in women should always involve a clinician who can put the number in the context of cycle timing, symptoms, and other hormones.

Tracking Your Trend

A single free testosterone reading is a snapshot, and testosterone genuinely varies week to week. Older men have shown values that fall in the normal range one week and the low range another, without any change in health. That is why guidelines require two morning fasting samples before diagnosing low testosterone, and why serial tracking beats any single number.

A sensible approach: get a baseline paired with total testosterone, SHBG, and albumin. If your level is unexpectedly low or you have symptoms, repeat in a morning fasting sample within a few weeks to confirm. If you are making changes such as weight loss, exercise, or treatment, retest at 3 to 6 months, then at least annually. Trends are far more informative than any single value, especially because the Vermeulen calculation carries a positive bias of roughly 20 percent versus the gold-standard equilibrium dialysis method.

When Results Can Be Misleading

Because Vermeulen free testosterone is calculated from total testosterone, SHBG, and albumin, anything that distorts those inputs distorts the result. Reference ranges also vary by lab and are not standardized across methods, so a value that looks abnormal in one lab may not in another.

  • Time of day and fasting: testosterone peaks in the morning and drifts down through the day. Draw blood before 10 a.m. after an overnight fast for the most interpretable result.
  • Acute illness or infection: short-term illness can suppress testosterone temporarily. A reading taken during or shortly after an acute event can look falsely hypogonadal.
  • A recent oral glucose load or large meal: a glucose challenge drops total testosterone by roughly 25 percent, and a mixed meal can drop it by around 123 ng/dL, with effects starting within about 20 minutes and peaking around 60 minutes. Draw fasting, not after a big breakfast.
  • Fixed albumin assumption: many labs plug a standard albumin value (around 43 g/L) into the Vermeulen formula. In marked hypoalbuminemia or advanced liver disease, this can distort the estimate. Ask your lab if measured albumin was used.

Medications That Can Shift the Number Without Causing Low Testosterone

Some drugs lower or raise this number through side effects on binding proteins or metabolism, without actually damaging your testicular function. Atorvastatin has been associated with lower total testosterone in men with type 2 diabetes, with a dose-response effect above 20 mg, though free and bioavailable testosterone were largely unchanged in the same analysis. Metformin can blunt or reduce testosterone gains that would otherwise occur with improved glycemic control, producing a relative reduction compared with other treatments rather than an absolute suppression. GLP-1 receptor agonists (drugs like semaglutide and tirzepatide, used for diabetes and weight loss) shift SHBG and total testosterone, but their effect on free testosterone specifically has been inconsistent across studies. If you are on any of these, tell the clinician interpreting your result.

What an Out-of-Pattern Result Should Prompt

A single low free testosterone is a signal to investigate, not a diagnosis. The reasonable next steps are a repeat morning fasting sample to confirm, alongside total testosterone, SHBG, and albumin so the calculation makes sense. If low is confirmed, LH and FSH help identify whether the issue is at the testicular level (primary) or at the pituitary or hypothalamus (secondary), and prolactin helps rule out a pituitary cause. Estradiol matters if you are considering treatment or evaluating symptoms of estrogen excess.

If your total testosterone is normal but free testosterone is low, the likely explanation is elevated SHBG, often driven by aging, thyroid issues, or liver factors. If free testosterone is high in a woman with irregular cycles, acne, or unwanted hair growth, workup for PCOS or adrenal androgen excess is warranted. In both cases, an endocrinologist or reproductive medicine specialist is the right level of care, especially before starting hormone therapy, which carries real trade-offs including fertility suppression, blood-count changes, and prostate considerations in men.

What Moves This Biomarker

Evidence-backed interventions that affect your Free Testosterone level

↑ Increase
Testosterone replacement therapy (TRT) with transdermal gel
If you have confirmed low testosterone with symptoms, transdermal TRT raises free testosterone into the target range quickly and reliably. In a randomized trial of 274 frail older men, transdermal testosterone at 50 mg/day pushed total and free testosterone into the target range by day 10 and held it for the full 6 months of treatment. TRT is the standard-of-care intervention for confirmed male hypogonadism, but requires ongoing monitoring of PSA, hematocrit, and estradiol, and is not appropriate if you are trying to conceive because it suppresses natural sperm production.
MedicationStrong Evidence
↑ Increase
Testosterone undecanoate injections
Long-acting testosterone injections raise free testosterone into the normal range and improve sexual function. In a 30-week randomized placebo-controlled trial of 199 men with type 2 diabetes and hypogonadism, 1,000 mg testosterone undecanoate injections improved erectile function, desire, and satisfaction as early as 6 weeks, with erectile function scores improving 4.31 points by 18 months. Like all TRT, this suppresses sperm production and requires monitoring.
MedicationStrong Evidence
↑ Increase
GLP-1 receptor agonists (tirzepatide, liraglutide)
In men with obesity-related low testosterone, GLP-1 based weight-loss therapy raises free testosterone by reducing fat mass and restoring signaling from the brain to the testes. In a controlled study of 83 men with obesity and metabolic hypogonadism, tirzepatide at 2.5 mg weekly escalated to 5 mg weekly over 2 months produced greater increases in LH, FSH, SHBG, total testosterone, and free testosterone than lifestyle alone. In 30 obese men with functional hypogonadism, liraglutide 3.0 mg daily for 16 weeks raised total testosterone and increased LH and FSH, indicating recovery of the natural hormone axis rather than just a binding-protein shift.
MedicationModerate Evidence
↑ Increase
Regular resistance training combined with testosterone therapy
Regular exercise pairs well with testosterone therapy to improve body composition in men with hypogonadism. Observational data in hypogonadal men treated with intramuscular testosterone show that gains in lean body mass are largest when treatment is paired with exercise habits, rather than with exercise alone or TRT alone. Exercise by itself is not a reliable way to raise free testosterone in men who are already hypogonadal, but it amplifies the benefits of treatment when hypogonadism is confirmed.
ExerciseModerate Evidence
↑ Increase
Intensive weight loss through diet and exercise
Sustained weight loss modestly raises SHBG and total testosterone in older obese men, but the effect on free testosterone specifically is small and often insufficient to move a clearly low value into the normal range. In 83 older obese hypogonadal men, 6 months of intensive diet and exercise produced meaningful weight loss and higher SHBG, but did not clearly raise free testosterone or move total testosterone into a clinically meaningful range. Lifestyle remains the first-line recommendation because of its broader health benefits, but for many men with confirmed hypogonadism, weight loss alone is not enough.
LifestyleModest Evidence

Frequently Asked Questions

References

23 studies
  1. Fiers T, Wu FCW, Moghetti P, Vanderschueren D, Lapauw B, Kaufman JMThe Journal of Clinical Endocrinology & Metabolism2018
  2. Narinx N, David K, Walravens J, Vermeersch P, Claessens F, Fiers T, Lapauw B, Antonio L, Vanderschueren DCellular and Molecular Life Sciences2022
  3. Narinx N, Nyamaah JA, David K, Sommers V, Walravens J, Fiers T, Lapauw B, Decallonne B, Claessens F, Van Uytfanghe K, Billen J, Vermeersch P, Vanderschueren D, Antonio LClinical Chemistry and Laboratory Medicine2025
  4. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FCW, Yialamas MAThe Journal of Clinical Endocrinology and Metabolism2018